Clinical Trial Update: Dynepo Infrequent Dosing Study [Phase 3]

View source ↗

Summary

Phase 3 trial of Dynepo for anemia related to kidney failure was terminated; results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Kidney Failure

Drugs mentioned

• Dynepo

Snippet

Sponsor: Shire | Conditions: Anemia, Kidney Failure | Phase 3 | Status: TERMINATED | Results posted: 2009-11-10